Cerebral Infarctions Completed Phase 3 Trials for Acetylsalicylic acid (DB00945)

Also known as: Cerebral Infarct / Cerebral Infarction / Stroke NOS / Infarct cerebral

IndicationStatusPhase
DBCOND0047013 (Cerebral Infarctions)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00129805Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS)Prevention
NCT00202020Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of StrokePrevention